Levels of different arachidonate metabolites in synovial fluid of arthrosic or rheumatoid joint effusions;LIVELLI DI DIFFERENTI METABOLITI DELL'ACIDO ARACHIDONICO NEL LIQUIDO SINOVIALE DI PAZIENTI CON ARTROSI O CON ARTRITE REUMATOIDE

Minerva Medica

Volumn 87, Issue 3, 1996, Pages 75-79

  Grignani, G ^a   Zucchella, M ^a   Beyene, N Belai ^a   Brocchieri, A ^a   Saporiti, A ^a   Ligniére, E L Chériè ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

arachidonic acid; arthrosis; metabolites; rheumatoid arthritis; synovial fluid

Indexed keywords

ARACHIDONIC ACID; LEUKOTRIENE B4; LEUKOTRIENE C4; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN F2 ALPHA; STEROID; THROMBOXANE B2;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; OSTEOARTHRITIS; RADIOIMMUNOASSAY; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

6-KETOPROSTAGLANDIN F1 ALPHA; ARACHIDONIC ACID; ARTHRITIS, RHEUMATOID; HUMANS; JOINT DISEASES; LEUKOTRIENE B4; LEUKOTRIENE C4; RADIOIMMUNOASSAY; SYNOVIAL FLUID; THROMBOXANE B2;

EID: 0029888414     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Kageyama Y, Koide Y, Miyamoto S, Yoshida TO, Inoue T. Leukotriene B4-induced interleukin-1 beta in synovial cells from patients with rheumatoid arthritis. Scand J Reumatol 1994,23 148-50.
2. Crofford LJ, Wilder RL, Ristimaki AP et al. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorhol esters, and corticosteroids. J Clin Invest 1994; 93:1095-101
3. Deleuran B, Iversen L. Kristensen M et al. Interleukin-8 secretion and 15-lypoxygenase activity in rheumatoid arthritis in vitro anti-inflammatory effects by interleukin-4 and interleukin-10. but not by interleukin-1 receptor antagonist protein Br J Rheumatol 1994,33:520-5
4. Wittenberg RH, Willburger RE, Kleemeyer KS, Peskar BA. In vitro release of prostaglandins and leukotrienes from synovial tissue, cartilage, and bone in degenerative joint diseases Arthritis Rheum 1993;36:1444-50.
5. Robinson DR Lipid mediators of inflammation. Rheumat Dis Clin North Am 1987,13:385-405
6. Westacott CL, Whicher JT, Barnes IC, Thompson D, Swan AJ. Dieppe PA Synovial fluid concentration of five different cytokines in rheumatic diseases Ann Rheum Dis 1990;49:676-81.
7. Miltenburg AMM, Yan Laar JM, De Kuiper R, Daha MR, Breedveld FC Interleukin-6 activity in paired samples of synovial fluids Correlation of synovial fluid interleukin-6 levels with clinical and laboratory parameters of inflammation. Br J Rheumatol 1991; 30 186-9.
8. Tetta C, Camussi G, Modena V, Di Vittorio C, Baglioni C. Tumor necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis Ann Rheum Dis 1990;49:665-7
9. Verburg CA, Hart MHL, Aarden LA, Swaak AJG Interleukin-8 (IL-8) in synovial fluids of rheumatoid and non rheumatoid joint effusions. Clin Rheumatol 1993,12:494-9.
10. Balblanc JC, Vignon E, Mathieu P, Broquet P, Conrozier T, Richard M Cytokines. prostaglandin E2, phospholipase A2 et métalloproteases du liquide synovial dans l'arthrose Rev Rum Mal Osteoartic 1991;58 343-7
11. Arnett FC, Edworthy SM, Bloch DA et al The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
12. Pruzanski W, Vadas P, Stefanski E, Urowitz MB. Phospholipase A2 activity in sera and synovial fluids in rhematoid arthritis and osteoarthritis. Its possible role as a proinflammatory enzyme. J Rheumatol 1985;12 211-6
13. Balblanc JC, Conrozier T, Hartmann A, Mathieu P, Richard M, Vignon E Acide hyaluronique et phospholipase A2 sériques dans une population arthrosique. Rev Rhum Mal Osteoartic 1991,58:857-62.
14. Balhblanc JC, Conrozier T, Mathieu P et al. L'activité sérique de la phospholipase A2 dans l'arthrose Rev Rhum Mal Osteoartic 1994;61 311-7
15. Gautam SC, Chikkala NF, Hamilton TA. Anti-inflammatory action of IL-4. J Immunol 1992;148:1411-5.
16. Miossec P, Briolay J Dechannte J, Wijdenes J, Martinez-Valdez H, Banchereau J Inhibition of production of proinflammatory cytokines and immunoglobulins by interleukin-4 in an ex vivo model of rheumatoid synovitis. Arthritis Rheum 1992,35:874-83
17. Gilman SC, Chang J, Zeigler PR, Uhl J, Mochan E. Interleukin-1 activates pospholipase A2 in human, synovial cells. Arthritis Rheum 1988;31.126-30
18. 2 activity, prostaglandins, neutral protease and collagenase activity in rheumatoid synovial fluid. Semin Arthritis Rheum 1989,18:11-5
19. Baum C, Kennedy DL, Forbes MB. Utilization of nonsteroidal antinflammatory drugs. Arthritis Rheum 1985;28:686-92
20. Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR. Selectivity of nonsteroidal antinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 1993;90:11693-7.
21. Appleton I, Tomlinson A, Willoughby DA. Inducible cyclooxigenase (Cox-2), a safer therapeutic target? Br J Rhematol 1994;33:410-2.